Cancer stem cell marker expression alone and in combination with microvascular invasion predicts poor prognosis in patients undergoing transplantation for hepatocellular carcinoma - 28/07/16
Abstract |
Background |
The cancer stem cell hypothesis provides an explanation for hepatocellular carcinoma (HCC) heterogeneity. We investigated the expression of CD44 and CD133 alone and in combination with microvascular invasion (MVI) as predictors of prognosis in patients undergoing liver transplantation for HCC.
Methods |
Explanted livers from 95 patients transplanted for HCC were analyzed. Marker expression was evaluated by immunofluorescence.
Results |
Seventy-seven patients were male with a mean age of 56 years. The most common etiologies of cirrhosis were hepatitis C (50%) and alcoholic liver disease (41%). Forty-one patients had laboratory model for end-stage liver disease score greater than 15. Overall survival (OS) at 1-, 3-, and 5-years was 86%, 75%, and 64%, respectively. Recurrence rate was 13% with a median follow-up of 64 months. The 5-year OS was significantly lower in those patients with MVI and CD44 (36.9%) or CD133 (40%). CD44+ and CD133+ correlated with increased risk of poorly differentiated HCC, and elevated alpha-fetoprotein levels. In combination with MVI, both markers were independently associated with increased recurrence and worse OS (recurrence P < .003, odds ratio = 8.05; P = .001, odds ratio = 9.5, survival P = .001, HR = 3.7; P = .004, HR = 3.2 respectively).
Conclusions |
CD44 or CD133 alone and in combination with MVI are independent predictors of poor prognosis in patients undergoing transplantation for HCC.
Le texte complet de cet article est disponible en PDF.Highlights |
• | CD44 and CD133, correlated with tumor differentiation and elevated AFP levels. |
• | In combination with MVI, CD44 and CD133 predict tumor recurrence and patient survival. |
• | This is the first report correlating LCSC markers and poor prognosis in HCC after OLT. |
Keywords : Liver cancer stem cells, Hepatocellular carcinoma, Liver transplantation, Outcomes, Prognostic factors
Plan
| The authors declare no conflicts of interest. |
Vol 212 - N° 2
P. 238-245 - août 2016 Retour au numéro
Article précédent
- Venous thromboembolism after traumatic amputation: an analysis of 366 combat casualties
- Matthew Hannon, Matthew D. Tadlock, Ted Melcer, Jay Walker, Jesse Bandle, Kameran Nieses, Michael Galarneau
- Computed tomography to operating room in less than 3 hours minimizes complications from appendicitis
- Laura A. Harmon, Matthew L. Davis, Daniel C. Jupiter, Richard C. Frazee, Justin L. Regner
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?